Skip to main content
Clinical Trials/CTRI/2026/04/108138
CTRI/2026/04/108138Not yet recruitingPhase 2/3

Clinical Trial For Assessing The Efficacy Of Mandukparni Siddhataila Shirobasti in The Management Of Vishada (Depression)

CSMSS Ayurved Mahavidyala and Rugnalaya Kanchanwadi Aurangabad Maharashtra1 site in 1 country40 target enrollmentStarted: April 20, 2026Last updated:

Trial Snapshot

Phase
Phase 2/3
Status
Not yet recruiting
Sponsor
Enrollment
40
Locations
1

Study Overview

Brief Summary

Depression continues to be one of the leading causes of disability worldwide  The

World Health Organization WHO reports that over 300 million people suffer from

depression globally and despite the availability of pharmaceutical treatments many

individuals do not find sufficient relief or experience significant side effects

Limitations of Conventional Treatment

Current antidepressants although effective for some come with significant

limitations such as delayed onset of action side effects like weight gain sexual

dysfunction and cognitive impairment as well as the risk of relapse after

discontinuation This highlights the need for alternative therapies that are safe

natural and effective

The Role of Ayurveda in Mental Health

Ayurveda with its holistic approach to health emphasizes the balance of body mind

and spirit Mandukparni is a herb recognized for its adaptogenic and nootropic

properties It is believed to improve cognitive function reduce anxiety and stabilize

mood, making it an ideal candidate for treating depression Siddhataila a medicated

oil is traditionally used in therapeutic procedures like Shirobasti to balance the

doshas and restore mental harmony

Study Design

Study Type
Interventional
Allocation
Na
Masking
None

Eligibility Criteria

Ages
18.00 Year(s) to 50.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Dignosed patients of vishada (Depression) having clinical features like Dukkhtvam Nidravaishamya, Manah khedah Chittodvega Asiddhi bhaya Anabhiruchi Age cadre 18 to 50 years Patients of either gender, irrespective of socioeconomic status Patient willing to sign the informed consent form Patient with history of Vishada (Depression) less than one year.

Exclusion Criteria

  • Patient age group of below 18 and above 50 years Shirobasti ayogya Patient which are not willing to do shirobasti Patient with major depressive disorder Pregnant women and children Patients with chronic illness like Cancer Hypertension Diabetes Mellitus Hyperthyroidism and Hypothyroidism Patients with Suicidal tendency and thoughts.

Investigators

Sponsor
CSMSS Ayurved Mahavidyala and Rugnalaya Kanchanwadi Aurangabad Maharashtra
Sponsor Class
Private medical college
Responsible Party
Principal Investigator
Principal Investigator

Dr Shivam Ramkishan Parihar

C.S.M.S.S Ayurved Mahavidyala And Rugnalaya Kanchanwadi Aurangabad

Study Sites (1)

Loading locations...

Similar Trials